Transplantation of allogenic cells in the therapy of patients with dilated cardiomyopathy.

Autor: Kirillov AM; B. V. Petrovskii Russian Research Surgical Center, Russian Academy of Medical Sciences, Moscow., Fatkhudinov TKh, Dyachkov AV, Koroteev AV, Goldshtein DV, Bochkov NP
Jazyk: angličtina
Zdroj: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2007 Oct; Vol. 144 (4), pp. 635-9.
DOI: 10.1007/s10517-007-0392-4
Abstrakt: We carried out a pilot study on intracoronary transplantation of prenatal allogenic skeletal myoblasts and multipotent bone marrow stromal cells to patients with dilated cardiomyopathy. Intracoronary transplantation of allogenic cells is a feasible and safe procedure: there were no life-threatening rhythm and conduction disturbances, symptoms of hemodynamic instability, and thromboembolic complications. Positive clinical effect of cell transplantation persisted for 6 months and consisted in decreased content of brain natriuretic peptide and improved tolerance to physical exercises. We observed no reliable dynamics of the major echocardiographic parameters and their correlations with patient's status.
Databáze: MEDLINE